These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1813360)

  • 1. Enzyme negative blastic transformation of chronic myeloproliferative disorders: immunophenotyping of the blastic cell population.
    Matolcsy A; Izer I; Magyarlaki T; Baranyay F
    Haematologia (Budap); 1991; 24(1):27-37. PubMed ID: 1813360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloproliferative disorders (CMPD).
    Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
    Pathol Res Pract; 1984 Nov; 179(2):131-86. PubMed ID: 6395125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunophenotype of blast crisis in chronic myeloid leukemia].
    Favre G; Passweg J; Hoffmann T; Speck B; Gratwohl A; Tichelli A
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1624-6. PubMed ID: 9824896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):471-85. PubMed ID: 3074744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
    Schmetzer HM; Gerhartz HH
    Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
    Matolcsy A; Kónya T; Wéber E
    Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia.
    López-Karpovitch X; Cárdenas R; Piedras J
    Rev Invest Clin; 1997; 49(1):31-6. PubMed ID: 9229753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic criteria for classification and differential diagnosis of chronic myeloproliferative disorders.
    Frisch B; Bartl R; Burkhardt R; Jäger K
    Haematologia (Budap); 1984; 17(2):209-26. PubMed ID: 6534829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival.
    Urbano-Ispizua A; Cervantes F; Matutes E; Villamor N; Pujades A; Sierra J; Feliu E; Vives-Corrons JL; Montserrat E; Rozman C
    Leukemia; 1993 Sep; 7(9):1349-54. PubMed ID: 8371586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
    Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
    Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of immunophenotype, genotype, and lineage fidelity in blastic transformation of chronic myelogenous leukemia: a study of 20 cases.
    Adachi K; Okumura M; Tanimoto M; Morishima Y; Ohno R; Saito H
    J Lab Clin Med; 1988 Jan; 111(1):125-32. PubMed ID: 3422082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
    Buhr T; Georgii A; Choritz H
    Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
    Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A "primitive" variant of the blast crisis in chronic myeloleukemia].
    Baryshnikov AIu; Turkina AG; Moiseenkova IN; Frolova EA; Sediakhina NP; Diagileva OA; Khoroshko ND; Mokeeva RA
    Ter Arkh; 1995; 67(7):22-5. PubMed ID: 7482298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
    Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M
    Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The onset of CML in blastic crisis: molecular features.
    Gregorini A; Filippetti A; Luchetti F; Walker A; Lillington DM; Papa S; Valentini M
    J Biol Regul Homeost Agents; 1997; 11(3):111-4. PubMed ID: 9498160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blast crisis of chronic myelogenous leukemia with blasts expressing both immature B lymphocyte- and myelomonocyte-associated antigens and differentiating into basophils in vitro].
    Utsunomiya Y; Iwamasa K; Yasukawa M; Tamai T; Shiosaka T; Bando S
    Rinsho Ketsueki; 1990 Jul; 31(7):1017-21. PubMed ID: 2214182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia.
    Hirayama Y; Kohgo Y; Kanisawa Y; Fujii S; Ikeda K; Matsunaga T; Ito Y; Sakamaki S; Niitsu Y
    Int J Hematol; 1993 Jun; 57(3):265-8. PubMed ID: 8364189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
    Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
    Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.